Method for ascertaining interferents in small liquid samples in an automated clinical analyzer
Accelerating the delivery of small samples for clinical analysis on an automated clinical analyzer by automatically inspecting for the presence of interferents like those that might be found within such samples after clinical analysis is commenced.
1 . A method for determining the presence of interferents within clinical analysis samples on an automated clinical analyzer by:
aspirating a first aliquot portion of sample to be analyzed at a first moment in time;
initiating the clinical analysis scheduled to be performed;
aspirating a second aliquot portion of sample to be analyzed at a second moment in time, wherein said second moment in time is subsequent to said first moment in time;
initiating a measurement for the presence of interferents within said second aliquot portion of sample after clinical analysis is commenced; and,
reporting the presence of interferents within said second aliquot portion of sample.
2 . The method of claim 1 wherein the interferents are one or more of hemolysis, icteris and lipemia.
3 . The method of claim 1 wherein the interferents are one or more of clots, bubbles or foam.
4 . The method of claim 1 wherein first aliquot portion of sample to be analyzed is a smaller portion in the range of about 1-2 uL and the second aliquot portion of sample is a larger portion in the range of about 10 uL.
5 . The method of claim 2 wherein the measured presence of hemolysis, icteris and lipemia are converted into indexes that increase incrementally as the level of hemolysis, icteris and lipemia increase and represent the ‘H’ index, the ‘I’ index, and the ‘L’ index, respectively.
6 . The method of claim 5 further comprising recording the measured presence of interferents as a 3-digit integer Sample Index in which the first digit represents the ‘H’ index, the second digit represents the ‘I’ index, and the last digit represents the ‘L’ index.
7 . The method of claim 6 further comprising assigning a 3-digit as an Alert Index integer to the clinical analysis scheduled to be performed and comparing said Alert Index to said Sample Index.
8 . The method of claim 7 further comprising reporting the comparison of Alert Index to said Sample Index as part of reporting the results of the clinical analysis scheduled to be performed.
9 . The method of claim 3 further comprising recording the measured presence of interferents as a 3-digit integer Sample Index in which the first digit represents the ‘H’ index, the second digit represents the ‘I’ index, and the last digit represents the ‘L’ index.
10 . The method of claim 3 wherein the measured presence of clots, bubbles or foam comprises measuring air pressure during aspiration of the larger sample aliquot portion and determining whether or not the monitored pressure remained within a range of values predetermined for samples without the presence of clots, bubbles, or foam.
11 . The method of claim 10 further comprising whether or not the monitored pressure remained within the predetermined range as part of reporting the results of the clinical analysis scheduled to be performed.
12 . A device for determining the presence of interferents within clinical samples scheduled to be analyzed on an automated clinical analyzer, the device comprising:
a probe adapted for aspirating a first aliquot portion of sample to be analyzed at a first moment in time;
a computer within said analyzer programmed to initiate the clinical analysis scheduled to be performed on said first aliquot portion of sample;
the probe also adapted for aspirating a second aliquot portion of sample to be analyzed at a second moment in time, wherein the second moment in time is subsequent to said first moment in time;
the computer also programmed to initiate measurements after said second moment in time for the presence of interferents within said second aliquot portion of sample, and to report the presence of interferents within said second aliquot portion of sample.
13 . The device of claim 1 wherein the interferents are one or more of hemolysis, icteris and lipemia.
14 . The device of claim 1 wherein the interferents are one or more of clots, bubbles or foam.
15 . The device of claim 1 wherein first aliquot portion of sample to be analyzed is a smaller portion in the range of about 1-2 uL and the second aliquot portion of sample is a larger portion in the range of about 10 uL.